120 participants
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-25
- Start Date:
- 2026-09-30
- Completion:
- 2027-05-31
Conditions
- Atherosclerosis
- Cardiovascular Disease
- Obesity
- Hypertension
- Diabetes Mellitus, Type 2
- Renal Insufficiency, Chronic
Interventions
- DRUG
No Results Yet